IDEAYA Biosciences, Inc. Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
IDEAYA Biosciences, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • IDEAYA Biosciences, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $519M, a 32.7% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $519M +$128M +32.7% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $590M +$318M +117% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $368M +$71.9M +24.3% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $317M +$32.6M +11.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $391M +$171M +78.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $272M +$74.9M +38% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $296M +$141M +91.4% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $284M +$128M +82.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $220M +$35.8M +19.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $197M +$31.7M +19.2% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $155M -$56.8M -26.9% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $156M -$41.3M -20.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $184M +$161M +703% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $166M +$113M +216% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $212M +$147M +226% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $197M +$127M +180% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $22.9M -$9.18M -28.6% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $52.4M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $64.9M -$4.57M -6.58% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $70.5M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $32M Jun 30, 2019 10-Q 2019-08-12
Q4 2018 $69.5M Dec 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.